FDA approves Ionis' Olezarsen?
Market price history
Rolling 7-day window of market YES price with the OU fair-price range overlay.
Not enough history yet for a chart.
New points land on each refresh — check back shortly.
New points land on each refresh — check back shortly.
Market price
YES85¢ (85%)
NO15¢ (15%)
Latest refresh · prices in cents
Polymarket • Volume: $769 • Updated 4h agoCloses: 2026-06-30 (25d)
Polymarket · Companies
OU's Pick
YES at 85¢ · pays 1.2×
Price gap
Polymarket85¢
→OU's fair99¢
+14¢ underpriced · pays 1.2×
Confidence
Moderate
The FDA already approved Olezarsen under the brand name Tryngolza for familial chylomicronemia syndrome on December 19 2024 according to official company and regulatory reports.
Wide edge+14¢
Affiliate link — we may earn a commission. Not financial advice. For informational purposes only. Prediction markets involve risk of loss. AI may contain errors.